At Galyatech, we have something at stake: our kids are sick. The success of GALYA-1 is vital to the treatment of our kids, and our drive to develop GALYA-1 comes from our parent-strength passion.
We are not developing remedies for multiple diseases. We're focused on treatments for one disease – NPC – starting with GALYA-1. We will not get sidetracked. We know what is at stake.
Drive Down Costs
Gene therapy is usually expensive. We will make every effort drive down the cost of GALYA-1 so that it is available to more NPC patients.
A human's a human, no matter how small. We do humane tests on animals to save human lives. We will not destroy or kill a human to bring this drug to life.